PD

Priyanka Devidas Kathane

Active Director Director DIN 11236223
DIN 11236223 First appointment Aug 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Priyanka Devidas Kathane

Data last updated:

Priyanka Devidas Kathane is a Director at Biobizz Technology Private Limited (since 2025). The company operates in Healthcare.

DIN 11236223
Primary Designation Director
Industry Healthcare
First Appointment 11 Aug 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biobizz Technology Private Limited U62091DL2024PTC434340
Director11 Aug 2025Active

Directorship timeline

Open interactive timeline →
Biobizz Technology Private Limited
Premium access

Shareholding and investment profile for Priyanka Devidas Kathane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Devidas Kathane

Priyanka Devidas Kathane currently holds 1 directorship: Biobizz Technology Private Limited (Director, since 11 Aug 2025).

Priyanka Devidas Kathane was first appointed on 11 Aug 2025 as Director at Biobizz Technology Private Limited.

The current boards of Priyanka Devidas Kathane's companies include Bhagyashree Rahul Dhapodkar (Biobizz Technology Private Limited), Ranjeeta Jitendra Dewade (Biobizz Technology Private Limited), Santosh Kumar Singh (Biobizz Technology Private Limited), Shubham Singh (Biobizz Technology Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available